Loading clinical trials...
Loading clinical trials...
The purpose of this study is to establish the effectiveness and confirm the safety of the VizAblate System in the ablation of large (\> 5 cm) symptomatic uterine fibroids.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Gynesonics
NCT00050752 · Renal Tumor Histology, Cutaneous Leiomyoma, and more
NCT05922657 · Heavy Menstrual Bleeding, Abnormal Uterine Bleeding, and more
NCT05862272 · Uterine Fibroids, Endometriosis
NCT06538454 · Arterial Hypertension, Postmenopausal; Menorrhagia, and more
NCT06405997 · Sporadic Lymphangioleiomyomatosis, TSC-associated Lymphangioleiomyomatosis
Universidad Autonoma de Nuevo Leon (UANL)
Monterrey, Nuevo León
Maxima Medisch Centrum
Veldhoven, North Brabant
Vrije Universiteit Medisch Centrum
Amsterdam, North Holland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions